BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9039608)

  • 1. Renal cell cancer: incidence of hemorrhage on MR images in patients with chronic renal insufficiency.
    John G; Semelka RC; Burdeny DA; Kelekis NL; Woosley JT; Kettritz U; Freeman JA
    J Magn Reson Imaging; 1997; 7(1):157-60. PubMed ID: 9039608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ampullary carcinoma: demonstration by current MR techniques.
    Semelka RC; Kelekis NL; John G; Ascher SM; Burdeny D; Siegelman ES
    J Magn Reson Imaging; 1997; 7(1):153-6. PubMed ID: 9039607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholangiocarcinoma: spectrum of appearances on MR images using current techniques.
    Worawattanakul S; Semelka RC; Noone TC; Calvo BF; Kelekis NL; Woosley JT
    Magn Reson Imaging; 1998 Nov; 16(9):993-1003. PubMed ID: 9839983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cancer staging: comparison of contrast-enhanced CT and gadolinium-enhanced fat-suppressed spin-echo and gradient-echo MR imaging.
    Semelka RC; Shoenut JP; Magro CM; Kroeker MA; MacMahon R; Greenberg HM
    J Magn Reson Imaging; 1993; 3(4):597-602. PubMed ID: 8347952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging.
    Hecht EM; Israel GM; Krinsky GA; Hahn WY; Kim DC; Belitskaya-Levy I; Lee VS
    Radiology; 2004 Aug; 232(2):373-8. PubMed ID: 15215544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI of pancreatic metastases from renal cancer.
    Kelekis NL; Semelka RC; Siegelman ES
    J Comput Assist Tomogr; 1996; 20(2):249-53. PubMed ID: 8606232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant lesions of the liver with high signal intensity on T1-weighted MR images.
    Kelekis NL; Semelka RC; Woosley JT
    J Magn Reson Imaging; 1996; 6(2):291-4. PubMed ID: 9132092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI of carcinoid tumors: spectrum of appearances in the gastrointestinal tract and liver.
    Bader TR; Semelka RC; Chiu VC; Armao DM; Woosley JT
    J Magn Reson Imaging; 2001 Sep; 14(3):261-9. PubMed ID: 11536403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exophytic benign tumors of the liver: appearance on MRI.
    Bader TR; Braga L; Semelka RC
    Magn Reson Imaging; 2001 Jun; 19(5):623-8. PubMed ID: 11672619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of pseudocapsule of renal cell carcinoma with MR imaging and CT.
    Yamashita Y; Honda S; Nishiharu T; Urata J; Takahashi M
    AJR Am J Roentgenol; 1996 May; 166(5):1151-5. PubMed ID: 8615260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal lesion characterization with gadolinium-enhanced MR imaging: efficacy and safety in patients with renal insufficiency.
    Rofsky NM; Weinreb JC; Bosniak MA; Libes RB; Birnbaum BA
    Radiology; 1991 Jul; 180(1):85-9. PubMed ID: 2052729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual Assessment of the Intensity and Pattern of T1 Hyperintensity on MRI to Differentiate Hemorrhagic Renal Cysts From Renal Cell Carcinoma.
    Kim CW; Shanbhogue KP; Schreiber-Zinaman J; Deng FM; Rosenkrantz AB
    AJR Am J Roentgenol; 2017 Feb; 208(2):337-342. PubMed ID: 27845847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small bowel neoplastic disease: demonstration by MRI.
    Semelka RC; John G; Kelekis NL; Burdeny DA; Ascher SM
    J Magn Reson Imaging; 1996; 6(6):855-60. PubMed ID: 8956128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Imaging tumor extension of renal cell carcinomas with magnetic resonance tomography. Improved tumor-tissue contrast with Gd-DTPA-assisted spin-echo sequences and simultaneous fat suppression].
    Venz S; Hierholzer J; Keske U; Friedrichs R; Schröder R; Siewert C; Hosten N; Felix R
    Aktuelle Radiol; 1998 May; 8(3):119-24. PubMed ID: 9645248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging.
    Sasiwimonphan K; Takahashi N; Leibovich BC; Carter RE; Atwell TD; Kawashima A
    Radiology; 2012 Apr; 263(1):160-8. PubMed ID: 22344404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hepatic tumors: changes on MRI after hepatic arterial chemoembolization--preliminary findings.
    Semelka RC; Worawattanakul S; Mauro MA; Bernard SA; Cance WG
    J Magn Reson Imaging; 1998; 8(1):48-56. PubMed ID: 9500260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal lymphoma: demonstration by MR imaging.
    Semelka RC; Kelekis NL; Burdeny DA; Mitchell DG; Brown JJ; Siegelman ES
    AJR Am J Roentgenol; 1996 Apr; 166(4):823-7. PubMed ID: 8610558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characterization and staging of renal tumors: significance of MRI diagnostics].
    Kalinka A; Gerlach A; Arlart IP; Günes N; Hauser TK; Würstlin S; Bosse A
    Rofo; 2006 Mar; 178(3):298-305. PubMed ID: 16508837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilocular cystic nephroma: MR imaging appearance with current techniques, including gadolinium enhancement.
    Kettritz U; Semelka RC; Siegelman ES; Shoenut JP; Mitchell DG
    J Magn Reson Imaging; 1996; 6(1):145-8. PubMed ID: 8851419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of T1-Weighted MRI to Detect Intratumoral Hemorrhage Within Papillary Renal Cell Carcinoma as a Feature Differentiating From Angiomyolipoma Without Visible Fat.
    Murray CA; Quon M; McInnes MD; van der Pol CB; Hakim SW; Flood TA; Schieda N
    AJR Am J Roentgenol; 2016 Sep; 207(3):585-91. PubMed ID: 27275530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.